SCHEMBL4021311

SCHEMBL4021311

CC(C)Nc1nc(-c2ccccn2)nc(Cl)c1-c1c(F)cc(F)cc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 3/20 0.47
MAPT P10636 2/20 0.47
MITF O75030 1/20 0.47
LMNA P02545 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CYP1A2 P05177 1/20 0.46
HTT P42858 1/20 0.46
FFAR1 O14842 5/20 0.44
LIMK1 P53667 2/20 0.43
MAPK14 Q16539 2/20 0.43
LIMK2 P53671 1/20 0.43
METAP1 P53582 2/20 0.43
METAP2 P50579 1/20 0.43
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
HIF1A Q16665 2/20 0.39
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4022692 0.89 CYP1A2 (0.43) TRPM8MAPTMITFLMNASMN1; SMN2
SCHEMBL4028514 0.89 CYP1A2 (0.43) TRPM8MAPTMITFLMNASMN1; SMN2
SCHEMBL4017695 0.89 CYP1A2 (0.43) TRPM8MAPTMITFLMNASMN1; SMN2
SCHEMBL5739515 0.89 MEN1 (0.45) TRPM8MAPTMITFLMNASMN1; SMN2
SCHEMBL4022147 0.84 METAP1 (0.51) LMNASMN1; SMN2L3MBTL1HTTFFAR1
SCHEMBL4017115 0.80 GPR39 (0.41) SMN1; SMN2L3MBTL1HTTFFAR1MAPK14
SCHEMBL2835717 0.77 TRPM8 (0.34) TRPM8MAPK14
SCHEMBL15626310 0.75 FFAR1 (0.38) TRPM8CYP1A2FFAR1LIMK1MAPK14
SCHEMBL21171439 0.75 FFAR1 (0.38) TRPM8CYP1A2FFAR1LIMK1MAPK14
SCHEMBL4016503 0.75 HRH3 (0.39) TRPM8CYP1A2FFAR1LIMK1MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1504001-B1 2-(2-PYRIDYL)-5-PHENYL-6-AMINOPYRIMIDINE, METHOD AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION AND USE THEREOF FOR COMBATING NOXIOUS FUNGI BASF SE (DE) 2009-04-15 EP disclosed
US-7320975-B2 2-(2-pyridyl)-5-phenyl-6-aminopyrimidine, method and intermediate products for the production and use thereof for combating noxious fungi BASF AKTIENGESELLSCHAFT (DE) 2008-01-22 US disclosed
US-20050107401-A1 2- (2-pyridyl) -5-phenyl-6-aminopyrimidine, method and intermediate products for the production and use thereof for combating noxious fungi BASF AKTIENGESELLSCHAFT (DE) 2005-05-19 US disclosed
EP-1504001-A1 2-(2-PYRIDYL)-5-PHENYL-6-AMINOPYRIMIDINE, METHOD AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION AND USE THEREOF FOR COMBATING NOXIOUS FUNGI BASF Aktiengesellschaft (DE) 2005-02-09 EP disclosed
WO-2003070721-A1 2-(2-PYRIDYL)-5-PHENYL-6-AMINOPYRIMIDINE, METHOD AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION AND USE THEREOF FOR COMBATING NOXIOUS FUNGI BASF AKTIENGESELLSCHAFT (DE) 2003-08-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107401-A1 2- (2-pyridyl) -5-phenyl-6-aminopyrimidine, method and intermediate products for the production and use thereof for combating noxious fungi HAAO, HAO1, DAO TRPM8 4084/4885MAPT 4275/4885MITF 4545/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.